XPOVIO
Identification of Xpovio
| No description |
Google image searchProduct monograph
Active ingredient
selinexor, 20 MG
DIN: 02527677
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: FORUS THERAPEUTICS INC.
Date: 07-JUL-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XX — Other antineoplastic agents (ATC, ATC/DDD)
- L01XX66 — SELINEXOR (ATC/DDD)
